Advanced search
Publication Cover
Emerging Microbes & Infections Volume 3, 2014 - Issue 1
Submit an article Journal homepage
781
Views
25
CrossRef citations to date
0
Altmetric
Original Articles

Drug susceptibility profile and pathogenicity of H7N9 influenza virus (Anhui1 lineage) with R292K substitution

Xiaonan ZhangDepartment of Pathogen Diagnosis and Biosafety, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Zhigang SongDepartment of Pathogen Diagnosis and Biosafety, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Jing HeDepartment of Pathogen Diagnosis and Biosafety, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Hui-Ling YenState Key Laboratory of Emerging Infectious Disease, School of Public Health, University of Hong Kong, Hong Kong, China
,
Jianhua LiKey Lab of Medical Molecular Virology, School of Basic Medical Science, Fudan University, Shanghai 200032, China
,
Zhaoqin ZhuDepartment of Pathogen Diagnosis and Biosafety, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Di TianDepartment of Pathogen Diagnosis and Biosafety, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Wei WangDepartment of Pathogen Diagnosis and Biosafety, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Lei XuDepartment of Pathogen Diagnosis and Biosafety, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Wencai GuanDepartment of Pathogen Diagnosis and Biosafety, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Yi LiuDepartment of Pathogen Diagnosis and Biosafety, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Sen WangDepartment of Pathogen Diagnosis and Biosafety, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China;Key Lab of Medical Molecular Virology, School of Basic Medical Science, Fudan University, Shanghai 200032, China
,
Bisheng ShiDepartment of Pathogen Diagnosis and Biosafety, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Wanju ZhangDepartment of Pathogen Diagnosis and Biosafety, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Boyin QinAnimal Center, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Jialin CaiAnimal Center, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Yanmin WanScientific Research Center, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Chunhua XuAnimal Center, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Xiaonan RenAnimal Center, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Haili ChenDepartment of Pathogen Diagnosis and Biosafety, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Lu LiuScientific Research Center, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Yuqin YangAnimal Center, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Xiaohui ZhouAnimal Center, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Wenjiang ZhouAnimal Center, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Jianqing XuKey Lab of Medical Molecular Virology, School of Basic Medical Science, Fudan University, Shanghai 200032, China;Scientific Research Center, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Xiaoyan ZhangKey Lab of Medical Molecular Virology, School of Basic Medical Science, Fudan University, Shanghai 200032, China;Scientific Research Center, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, China
,
Malik PeirisState Key Laboratory of Emerging Infectious Disease, School of Public Health, University of Hong Kong, Hong Kong, China
,
Yunwen HuDepartment of Pathogen Diagnosis and Biosafety, Shanghai Public Health Clinical Center, Fudan University, Shanghai 201508, ChinaCorrespondence[email protected] [email protected]
&
Zhenghong YuanKey Lab of Medical Molecular Virology, School of Basic Medical Science, Fudan University, Shanghai 200032, ChinaCorrespondence[email protected] [email protected]
 show all
Pages 1-9 | Received 23 Sep 2015, Accepted 02 Nov 2015, Published online: 25 Jan 2019

  • Gao R, Cao B, Hu Y et al.Human infection with a novel avian-origin influenza A (H7N9) virus. N Engl J Med2013;368: 1888–1897.
  • Lam TT-Y, Wang J, Shen Y et al.The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature2013;502: 241–244.
  • Wu A, Su C, Wang D et al.Sequential reassortments underlie diverse influenza H7N9 genotypes in China. Cell Host Microbe2013;14: 446–452.
  • Liu D, Shi W, Shi Y et al.Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet2013;381: 1926–1932.
  • Wang D, Yang L, Gao R et al.Genetic tuning of the novel avian influenza A(H7N9) virus during interspecies transmission, China, 2013. Euro Surveill2014;19.pii: 20836
  • Ren L, Yu X, Zhao B et al.Infection with possible precursor of avian influenza A(H7N9) virus in a child, China, 2013. Emerg Infect Dis2014;20: 1362–1365.
  • McKimm-Breschkin JL.Influenza neuraminidase inhibitors: antiviral action and mechanisms of resistance. Influenza Other Respir Viruses2013;7(Suppl 1): 25–36.
  • Yen HL, Herlocher LM, Hoffmann E et al.Neuraminidase inhibitor-resistant influenza viruses may differ substantially in fitness and transmissibility. Antimicrob Agents Chemother2005;49: 4075–4084.
  • Yen HL, McKimm-Breschkin JL, Choy KT et al.Resistance to neuraminidase inhibitors conferred by an R292K mutation in a human influenza virus H7N9 isolate can be masked by a mixed R/K viral population. mBio2013;4.pii: e00396-13
  • Hu Y, Lu S, Song Z et al.Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance. Lancet2013;381: 2273–2279.
  • Lin PH, Chao TL, Kuo SW et al.Virological, serological, and antiviral studies in an imported human case of avian influenza A(H7N9) virus in Taiwan. Clin Infect Dis2014;58: 242–246.
  • Kageyama T, Fujisaki S, Takashita E et al.Genetic analysis of novel avian A(H7N9) influenza viruses isolated from patients in China, February to April 2013. Euro Surveill2013;18: 20453.
  • Wang W, Song Z, Guan W et al.PCR for detection of oseltamivir resistance mutation in influenza A(H7N9) virus. Emerg Infect Dis2014;20: 847–849.
  • Chou TC.Theoretical basis, experimental design, and computerized simulation of synergism and antagonism in drug combination studies. Pharmacol Rev2006;58: 621–681.
  • Chou TC.Drug combination studies and their synergy quantification using the Chou–Talalay method. Cancer Res2010;70: 440–446.
  • Zhu Z, Yang Y, Feng Y et al.Infection of inbred BALB/c and C57BL/6 and outbred Institute of Cancer Research mice with the emerging H7N9 avian influenza virus. Emerg Microbes Infect2013;2: e50.
  • Gao HN, Lu HZ, Cao B et al.Clinical findings in 111 cases of influenza A (H7N9) virus infection. N Engl J Med2013;368: 2277–2285.
  • Liu X, Li T, Zhen YF, Wong KW, Lu SH, Lu HZ.Poor responses to oseltamivir treatment in a patient with influenza a (H7N9) infection. Emerg Microbes Infect2013;2: e27.
  • Watanabe T, Kiso M, Fukuyama S et al.Characterization of H7N9 influenza A viruses isolated from humans. Nature2013;501: 551–555.
  • Sleeman K, Guo Z, Barnes J, Shaw M, Stevens J, Gubareva LV.R292K substitution and drug susceptibility of influenza A(H7N9) viruses. Emerg Infect Dis2013;19: 1521–1524.
  • Rong H, Schmolke M, Leyva-Grado VH et al.Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility. Nat Commun2013;4: 2854.
  • Marjuki H, Mishin VP, Chesnokov AP et al.An investigational antiviral drug, DAS181, effectively inhibits replication of zoonotic influenza A virus subtype H7N9 and protects mice from lethality. J Infect Dis2014;210: 435–440.
  • Yen HL, Zhou J, Choy KT et al.The R292K mutation that confers resistance to neuraminidase inhibitors leads to competitive fitness loss of A/Shanghai/1/2013 (H7N9) influenza virus in ferrets. J Infect Dis2014;June 20.doi:https://doi.org/10.1093/infdis/jiu353.
  • Baranovich T, Webster RG, Govorkova EA.Fitness of neuraminidase inhibitor-resistant influenza A viruses. Curr Opin Virol2011;1: 574–581.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.